Digg
Del.icio.us
Yahoo
Google
Newsvine
Sarah Cannon Research-United Kingdom
Advancing Therapies for Patients
Drug Development Program
The Sarah Cannon Research UK Drug Development Program offers consistent performance and excellence through:
- A dedicated and experienced oncology drug development team
- State-of-the-art clinical trials unit in central London
- Competitive start-up timelines
- Rapid patient accrual within a large referral network
- Interactive scientific collaboration
Our Facility
- New CQC-registered early oncology trials unit
- On-site pharmacy
- PK testing facilities
- -20 + -80 C freezers
- Refrigerated and non-refrigerated centrifuges
- Cardiac monitoring
- Access to hospital-based critical care services
For Patients
- Broad clinical trials portfolio
- Patient-centered support services and referrals
- Private areas for longer treatments
- Wireless internet and individual patient entertainment systems
- On-site catering for patients
For Partners
We are committed to our partners’ goals, and we tailor our teams and processes to meet them. Senior-level management and clinical staff stay involved throughout our working relationship, ensuring strong science and consistent quality every step of the way. We serve as collaborators and a clinical team, and we strive to provide better insights that contribute to success and discovery.
